Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Neutral Rating on Transocean with Adjusted Price Target

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Renewable-energy
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Piper Sandler analyst Ian Macpherson has reiterated a Neutral rating on Transocean (NYSE: RIG) on March 11, 2024. Macpherson has adjusted the price target downward from $7 to $6, citing his assessment of the company’s performance and valuation.

_____

Despite varying price targets from different analysts, the overall consensus on Transocean remains Neutral, with analysts having differing opinions on the target prices.

Transocean Ltd. (RIG) Sees Positive Momentum in Stock Performance on March 11, 2024

On March 11, 2024, Transocean Ltd. (RIG) saw some positive momentum in its stock performance. RIG is currently trading near the bottom of its 52-week range and below its 200-day simple moving average. Despite this, the stock saw a price increase of $0.10 since the market last closed, representing a 1.94% rise. RIG was trading at $5.25 per share at market close and continued to show upward movement in pre-market trading, rising by an additional $0.01. This suggests continued interest in RIG among investors. RIG’s performance on March 11th stands out against a challenging market environment, indicating underlying strength in the company or sector supporting its performance. Investors will likely be watching RIG closely in the coming days to see if this positive momentum can be sustained. It is important for investors to conduct their own research and consider their risk tolerance before making any investment decisions.

Transocean Ltd. Reports Mixed Financial Results for 2024: Revenue Growth but Decrease in Net Income

On March 11, 2024, the stock performance of Transocean Ltd. (RIG) was closely watched by investors as the company released its financial results for the past year and the fourth quarter. According to data from CNN Money, the company reported total revenue of $2.83 billion for the past year, representing a 9.98% increase compared to the previous year. For the fourth quarter, total revenue was reported at $741.00 million, showing a 3.93% increase compared to the previous quarter.

Despite the increase in total revenue, the company reported a net income of -$954.00 million for the past year, which was a significant decrease of 53.62% compared to the previous year. However, for the fourth quarter, the net income improved slightly to -$104.00 million, showing no change compared to the previous quarter.

Earnings per share (EPS) for the past year was reported at -$1.24, which was a decrease of 39.82% compared to the previous year. However, for the fourth quarter, EPS improved to -$0.13, showing a significant increase of 54.75% compared to the previous quarter.

Overall, the financial results of Transocean Ltd. on March 11, 2024, showed mixed performance indicators. While total revenue showed growth both for the past year and the fourth quarter, net income experienced a significant decrease for the past year. On the other hand, EPS showed improvement for the fourth quarter, indicating a potential turnaround in profitability for the company.

Investors will be closely monitoring future financial reports and company performance to assess the long-term outlook for RIG stock. The company’s ability to sustain revenue growth and improve profitability will be key factors in determining its stock performance in the coming months.

Tags: RIG
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Pharmaceutical Markets and money

Gilead Sciences Inc Completes Waiting Period for Tender Offer for CymaBay Therapeutics Inc

Exciting TopLine Results in Psoriatic Arthritis Trials

Biotechnology Stock Market Today (1)

Advancements in Precision Oncology Aprea Therapeutics and Cyteir Therapeutics Secure Significant Funding

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com